版本:
中国

BRIEF-Biosyent Q3 EPS C$0.08

Nov 23 Biosyent Inc :

* "expect to see significant growth in 2016 international pharmaceutical sales over 2015"

* Biosyent releases results for third quarter and first nine months of 2016

* Q3 revenue rose 3 percent to C$4.767 million Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐